XBI IBB Prediction market giant Kalshi announced this morning that it will now start taking bets on clinical trial outcomes and FDA approval
XBI IBB Prediction market giant Kalshi announced this morning that it will now start taking bets on clinical trial outcomes and FDA approvals, STAT News reported. It’s starting with a small number of markets selected alongside partner AppliedXL, a tech company that already monitors and predicts clinical trial outcomes. Link To Story from STATNEWS.com
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.